• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于经皮抗原递送的较小尺寸壳聚糖纳米胶囊

Lower-Sized Chitosan Nanocapsules for Transcutaneous Antigen Delivery.

作者信息

Bussio Juan I, Molina-Perea Carla, González-Aramundiz José Vicente

机构信息

Departamento de Farmacia, Facultad de Química, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.

Centro de Investigación en Nanotecnología y Materiales Avanzados "CIEN-UC", Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.

出版信息

Nanomaterials (Basel). 2018 Aug 26;8(9):659. doi: 10.3390/nano8090659.

DOI:10.3390/nano8090659
PMID:30149658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6164329/
Abstract

Transcutaneous vaccination has several advantages including having a noninvasive route and needle-free administration; nonetheless developing an effective transdermal formulation has not been an easy task because skin physiology, particularly the stratum corneum, does not allow antigen penetration. Size is a crucial parameter for successful active molecule administration through the skin. Here we report a new core-shell structure rationally developed for transcutaneous antigen delivery. The resulting multifunctional carrier has an oily core with immune adjuvant properties and a polymeric corona made of chitosan. This system has a size of around 100 nm and a positive zeta potential. The new formulation is stable in storage and physiological conditions. Ovalbumin (OVA) was used as the antigen model and the developed nanocapsules show high association efficiency (75%). Chitosan nanocapsules have high interaction with the immune system which was demonstrated by complement activation and also did not affect cell viability in the macrophage cell line. Finally, ex vivo studies using a pig skin model show that OVA associated to the chitosan nanocapsules developed in this study penetrated and were retained better than OVA in solution. Thus, the physicochemical properties and their adequate characteristics make this carrier an excellent platform for transcutaneous antigen delivery.

摘要

经皮接种疫苗具有多种优势,包括采用非侵入性途径且无需注射;然而,开发一种有效的透皮制剂并非易事,因为皮肤生理结构,尤其是角质层,不允许抗原穿透。尺寸是通过皮肤成功递送活性分子的关键参数。在此,我们报告一种为经皮递送抗原而合理开发的新型核壳结构。所得的多功能载体具有具有免疫佐剂特性的油性核心以及由壳聚糖制成的聚合物冠层。该系统尺寸约为100纳米,且具有正的zeta电位。新制剂在储存和生理条件下均稳定。卵清蛋白(OVA)用作抗原模型,所开发的纳米胶囊显示出高结合效率(75%)。壳聚糖纳米胶囊与免疫系统具有高度相互作用,这通过补体激活得以证明,并且对巨噬细胞系中的细胞活力没有影响。最后,使用猪皮肤模型进行的体外研究表明,与本研究中开发的壳聚糖纳米胶囊结合的OVA比溶液中的OVA穿透性更好且保留性更佳。因此,其物理化学性质及其适当特性使该载体成为经皮抗原递送的优良平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/ebfe438702f7/nanomaterials-08-00659-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/7bc8ea18ad09/nanomaterials-08-00659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/7dfa97f99adb/nanomaterials-08-00659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/c53d46f04cbd/nanomaterials-08-00659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/a030654f90fe/nanomaterials-08-00659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/e9c36fed6da0/nanomaterials-08-00659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/ebfe438702f7/nanomaterials-08-00659-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/7bc8ea18ad09/nanomaterials-08-00659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/7dfa97f99adb/nanomaterials-08-00659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/c53d46f04cbd/nanomaterials-08-00659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/a030654f90fe/nanomaterials-08-00659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/e9c36fed6da0/nanomaterials-08-00659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d0/6164329/ebfe438702f7/nanomaterials-08-00659-g006.jpg

相似文献

1
Lower-Sized Chitosan Nanocapsules for Transcutaneous Antigen Delivery.用于经皮抗原递送的较小尺寸壳聚糖纳米胶囊
Nanomaterials (Basel). 2018 Aug 26;8(9):659. doi: 10.3390/nano8090659.
2
Hyaluronic Acid Nanocapsules as a Platform for Needle-Free Vaccination.透明质酸纳米胶囊作为无针接种的平台
Pharmaceutics. 2019 May 26;11(5):246. doi: 10.3390/pharmaceutics11050246.
3
Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo.经皮免疫载抗原柔性脂质体体内有效。
Int J Nanomedicine. 2011;6:3241-50. doi: 10.2147/IJN.S26152. Epub 2011 Dec 8.
4
Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.经毛囊无创递呈纳米颗粒:经皮免疫的新视角。
Vaccine. 2013 Jul 25;31(34):3442-51. doi: 10.1016/j.vaccine.2012.12.048. Epub 2013 Jan 2.
5
Design of Chitosan Nanocapsules with Compritol 888 ATO® for Imiquimod Transdermal Administration. Evaluation of Their Skin Absorption by Raman Microscopy.壳聚糖纳米胶囊的设计 Compritol 888 ATO® 用于咪喹莫特经皮给药。拉曼显微镜评估其皮肤吸收。
Pharm Res. 2020 Sep 17;37(10):195. doi: 10.1007/s11095-020-02925-6.
6
Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy.多糖纳米胶囊中病毒蛋白和 TLR7 激动剂的共递送:一种无针疫苗接种策略。
J Control Release. 2013 Dec 28;172(3):773-81. doi: 10.1016/j.jconrel.2013.09.012. Epub 2013 Sep 25.
7
Galactosylated chitosan-modified ethosomes combined with silk fibroin nanofibers is useful in transcutaneous immunization.半乳糖化壳聚糖修饰的醇质体与丝素纳米纤维联合用于经皮免疫。
J Control Release. 2020 Nov 10;327:88-99. doi: 10.1016/j.jconrel.2020.07.047. Epub 2020 Aug 5.
8
Rational design of protamine nanocapsules as antigen delivery carriers.鱼精蛋白纳米胶囊作为抗原传递载体的合理设计。
J Control Release. 2017 Jan 10;245:62-69. doi: 10.1016/j.jconrel.2016.11.012. Epub 2016 Nov 14.
9
Polymeric Nanocapsules for Vaccine Delivery: Influence of the Polymeric Shell on the Interaction With the Immune System.聚合物纳米胶囊用于疫苗传递:聚合物壳层对与免疫系统相互作用的影响。
Front Immunol. 2018 Apr 19;9:791. doi: 10.3389/fimmu.2018.00791. eCollection 2018.
10
Dextran Nanocapsules with -3 in Their Nucleus: An Innovative Nanosystem for Imiquimod Transdermal Delivery.核内含有 -3 的葡聚糖纳米胶囊:一种用于咪喹莫特经皮递送的创新纳米系统。
Pharmaceutics. 2022 Nov 11;14(11):2445. doi: 10.3390/pharmaceutics14112445.

引用本文的文献

1
Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives.纳米制剂在药物和生物医学应用中的应用:绿色视角。
Int J Mol Sci. 2024 May 27;25(11):5842. doi: 10.3390/ijms25115842.
2
Super-Antioxidant Vitamin A Derivatives with Improved Stability and Efficacy Using Skin-Permeable Chitosan Nanocapsules.使用可透皮壳聚糖纳米胶囊的具有改善稳定性和功效的超级抗氧化剂维生素A衍生物
Antioxidants (Basel). 2023 Oct 26;12(11):1913. doi: 10.3390/antiox12111913.
3
Dextran Nanocapsules with -3 in Their Nucleus: An Innovative Nanosystem for Imiquimod Transdermal Delivery.

本文引用的文献

1
Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.载药 PLGA 纳米粒溶解微针的研制及其与空心微针在皮内疫苗传递中的比较。
Eur J Pharm Biopharm. 2018 Aug;129:111-121. doi: 10.1016/j.ejpb.2018.05.031. Epub 2018 May 24.
2
Are chitosan natural polymers suitable as adjuvant/delivery system for anti-tuberculosis vaccines?壳聚糖作为抗结核疫苗佐剂/递药系统合适吗?
Microb Pathog. 2018 Aug;121:218-223. doi: 10.1016/j.micpath.2018.05.035. Epub 2018 May 23.
3
Stratum corneum substantivity: drug development implications.
核内含有 -3 的葡聚糖纳米胶囊:一种用于咪喹莫特经皮递送的创新纳米系统。
Pharmaceutics. 2022 Nov 11;14(11):2445. doi: 10.3390/pharmaceutics14112445.
4
The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination.纳米载体设计与组成对高效纳米颗粒介导的经皮疫苗接种的重要性
Vaccines (Basel). 2021 Dec 1;9(12):1420. doi: 10.3390/vaccines9121420.
5
Polymer-Based Nanosystems-A Versatile Delivery Approach.基于聚合物的纳米系统——一种通用的递送方法。
Materials (Basel). 2021 Nov 11;14(22):6812. doi: 10.3390/ma14226812.
6
Formulation-based approaches for dermal delivery of vaccines and therapeutic nucleic acids: Recent advances and future perspectives.基于制剂的疫苗和治疗性核酸经皮递送方法:最新进展与未来展望
Bioeng Transl Med. 2021 May 4;6(3):e10215. doi: 10.1002/btm2.10215. eCollection 2021 Sep.
7
Capsaicin-Loaded Chitosan Nanocapsules for wtCFTR-mRNA Delivery to a Cystic Fibrosis Cell Line.用于将野生型囊性纤维化跨膜传导调节因子(wtCFTR)信使核糖核酸(mRNA)递送至囊性纤维化细胞系的载辣椒素壳聚糖纳米胶囊
Biomedicines. 2020 Sep 20;8(9):364. doi: 10.3390/biomedicines8090364.
8
Novel Clove Essential Oil Nanoemulgel Tailored by Taguchi's Model and Scaffold-Based Nanofibers: Phytopharmaceuticals with Promising Potential as Cyclooxygenase-2 Inhibitors in External Inflammation.新型丁香精油纳米乳凝胶的研制——基于田口模型和支架纳米纤维:作为外炎症中环氧化酶-2 抑制剂的有前途的植物药。
Int J Nanomedicine. 2020 Mar 30;15:2171-2195. doi: 10.2147/IJN.S246601. eCollection 2020.
9
Hyaluronic Acid Nanocapsules as a Platform for Needle-Free Vaccination.透明质酸纳米胶囊作为无针接种的平台
Pharmaceutics. 2019 May 26;11(5):246. doi: 10.3390/pharmaceutics11050246.
角质层附着性:药物开发的意义。
Arch Dermatol Res. 2018 Sep;310(7):537-549. doi: 10.1007/s00403-018-1841-9. Epub 2018 May 11.
4
Polymeric Nanocapsules for Vaccine Delivery: Influence of the Polymeric Shell on the Interaction With the Immune System.聚合物纳米胶囊用于疫苗传递:聚合物壳层对与免疫系统相互作用的影响。
Front Immunol. 2018 Apr 19;9:791. doi: 10.3389/fimmu.2018.00791. eCollection 2018.
5
Curdlan sulfate--linked quaternized chitosan nanoparticles: potential adjuvants to improve the immunogenicity of exogenous antigens via intranasal vaccination.硫酸几丁聚糖连接的季铵化壳聚糖纳米粒:通过鼻腔免疫接种提高外源性抗原免疫原性的潜在佐剂。
Int J Nanomedicine. 2018 Apr 18;13:2377-2394. doi: 10.2147/IJN.S158536. eCollection 2018.
6
Transdermal immunomodulation: Principles, advances and perspectives.经皮免疫调节:原理、进展与展望。
Adv Drug Deliv Rev. 2018 Mar 1;127:3-19. doi: 10.1016/j.addr.2018.03.010. Epub 2018 Mar 29.
7
Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications.纳米乳作为经皮和透皮给药的药物载体:制剂开发、稳定性问题、基本考虑因素和应用。
J Control Release. 2018 Jan 28;270:203-225. doi: 10.1016/j.jconrel.2017.11.049. Epub 2017 Dec 1.
8
Effects of Surface Charge of Hyperbranched Polymers on Cytotoxicity, Dynamic Cellular Uptake and Localization, Hemotoxicity, and Pharmacokinetics in Mice.超支化聚合物表面电荷对细胞毒性、细胞内动态摄取和定位、血液毒性以及在小鼠体内药代动力学的影响。
Mol Pharm. 2017 Dec 4;14(12):4485-4497. doi: 10.1021/acs.molpharmaceut.7b00611. Epub 2017 Nov 8.
9
Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases.壳聚糖基微粒系统用于递送针对传染病的粘膜疫苗。
Int J Biol Macromol. 2018 Apr 15;110:54-64. doi: 10.1016/j.ijbiomac.2017.10.101. Epub 2017 Oct 18.
10
Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization.新型溶解微针增强左炔诺孕酮经皮传递:体外与体内特性研究。
Int J Pharm. 2017 Dec 20;534(1-2):378-386. doi: 10.1016/j.ijpharm.2017.10.035. Epub 2017 Oct 16.